Validation of the pediatric refractory septic shock definition: post hoc analysis of a controlled trial

Luc Morin1, Karthik Narayanan Ramaswamy2, Muralidharan Jayashree2

  • 1Pediatric Intensive Care Unit, Bicêtre Hospital, AP-HP Paris-Saclay University, Le Kremlin-Bicêtre, France.

Annals of Intensive Care
|February 11, 2021
PubMed

Insights

The European Society of Pediatric and Neonatal Intensive Care (ESPNIC) refractory septic shock (RSS) definition accurately identifies children with a lethal outcome within 6 hours. This definition, using bedside and computed septic shock scores (bSSS and cSSS), shows high prognostic accuracy for pediatric septic shock mortality.

Area of Science:

  • Pediatric Intensive Care Medicine
  • Neonatal Intensive Care
  • Septic Shock Research

Background:

  • The European Society of Pediatric and Neonatal Intensive Care (ESPNIC) established a definition for pediatric refractory septic shock (RSS).
  • Both bedside septic shock scores (bSSS) and computed septic shock scores (cSSS) demonstrated a strong correlation with mortality.
  • This study evaluated the accuracy of the ESPNIC RSS definition in a prospective Indian cohort.

Purpose of the Study:

  • To assess the accuracy of the ESPNIC definition of pediatric refractory septic shock (RSS) in a prospective Indian cohort.
  • To determine the prognostic value of the RSS definition for 28-day all-cause mortality in children with septic shock.
  • To evaluate the performance of bedside (bSSS) and computed (cSSS) septic shock scores in identifying high-risk pediatric septic shock patients.

Main Methods:

  • A post hoc analysis was conducted on data from a double-blind randomized trial involving children with septic shock.
  • Sequential bSSS and cSSS data from 60 children were analyzed to assess the ESPNIC RSS definition's prognostic value.
  • The study focused on 28-day all-cause mortality as the primary outcome measure.

Main Results:

  • Refractory septic shock (RSS) was diagnosed in 58.3% of patients within the first 24 hours.
  • Mortality was significantly higher in RSS patients (85.7%) compared to non-RSS patients (8%).
  • Both bSSS and cSSS showed high discrimination for death (AUC 0.916 and 0.925, respectively), with optimal prognostication after 12 hours of treatment.

Conclusions:

  • The ESPNIC refractory septic shock definition effectively identifies children with a high risk of mortality.
  • The definition is accurate within the first 6 hours of managing pediatric septic shock.
  • bSSS and cSSS are valuable tools for predicting outcomes in pediatric septic shock.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
102
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
238
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
122
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
101
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
139
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
102